A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics (PK) of Oral TAK-994 in an Acute Sleep Phase Delay Paradigm in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 23, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-994

TAK-994 tablets.

DRUG

Placebo

TAK-994 placebo-matching tablets.

Trial Locations (1)

Clinilabs Drug Development Corporation, New York